Literature DB >> 9066047

Monoclonal antibodies against Babesia caballi and Babesia equi and their application in serodiagnosis.

A Brüning1, P Phipps, E Posnett, E U Canning.   

Abstract

The production of monoclonal antibodies to the bloodstages of the haemoprotozoan parasites Babesia caballi and Babesia equi and the characterization of their corresponding antigens are described. Species specific and immunogenic proteins of both parasites were identified using SDS-PAGE, Western blotting and ELISA. These proteins were then electroeluted from SDS-PAGE gels and used to immunize BALB/c mice for hybridoma production. One monoclonal antibody (Mab), designated BC5.37.70.27 (BC5), recognized a 70 kDa protein of B. caballi as demonstrated by Western blotting under reducing conditions. Another Mab, BE1.24/2.95 (BEI), recognized a 34 kDa protein of B. equi. Both Mabs reacted specifically in indirect ELISA when isolated whole merozoites were used as antigen. Preliminary studies using the two Mabs in a competitive ELISA (cELISA) suggest that the cELISA for the detection of B. caballi infection is more sensitive than the commonly used complement fixation test but that refinement is necessary for the B. equi system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066047     DOI: 10.1016/s0304-4017(96)01074-6

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  9 in total

1.  Cloning and expression of a 48-kilodalton Babesia caballi merozoite rhoptry protein and potential use of the recombinant antigen in an enzyme-linked immunosorbent assay.

Authors:  H Ikadai; X Xuan; I Igarashi; S Tanaka; T Kanemaru; H Nagasawa; K Fujisaki; N Suzuki; T Mikami
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  The 18 kDa antigen of Theileria equi is a specific but less abundant protein also expressed by parasites cultured in vitro.

Authors:  T Samuel; R Böse
Journal:  Vet Res Commun       Date:  2001-04       Impact factor: 2.459

3.  Cloning of a novel Babesia equi gene encoding a 158-kilodalton protein useful for serological diagnosis.

Authors:  Haruyuki Hirata; Naoaki Yokoyama; Xuenan Xuan; Kozo Fujisaki; Naoyoshi Suzuki; Ikuo Igarashi
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Development of Nested PCR and Duplex Real-Time Fluorescence Quantitative PCR Assay for the Simultaneous Detection of Theileria equi and Babesia caballi.

Authors:  Kunying Lv; Yiwei Zhang; Yixin Yang; Zheng Liu; Liang Deng
Journal:  Front Vet Sci       Date:  2022-05-18

5.  Diagnosis of Babesia caballi and Theileria equi infections in horses in Sudan using ELISA and PCR.

Authors:  B O M Salim; S M Hassan; M A Bakheit; A Alhassan; I Igarashi; P Karanis; M B Abdelrahman
Journal:  Parasitol Res       Date:  2008-07-10       Impact factor: 2.289

6.  Molecular cloning of a Babesia caballi gene encoding the 134-kilodalton protein and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.

Authors:  Yoh Tamaki; Haruyuki Hirata; Noriyuki Takabatake; Sabine Bork; Naoaki Yokoyama; Xuenan Xuan; Kozo Fujisaki; Ikuo Igarashi
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

7.  Monoclonal antibody against Babesia equi: characterization and potential application of antigen for serodiagnosis.

Authors:  A Avarzed; I Igarashi; D T De Waal; S Kawai; Y Oomori; N Inoue; Y Maki; Y Omata; A Saito; H Nagasawa; Y Toyoda; N Suzuki
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Piroplasmosis in an endemic area: analysis of the risk factors and their implications in the control of Theileriosis and Babesiosis in horses.

Authors:  Eleonora Guidi; Sophie Pradier; Isabelle Lebert; Agnes Leblond
Journal:  Parasitol Res       Date:  2014-10-04       Impact factor: 2.289

9.  First Case of Autochthonous Equine Theileriosis in Austria.

Authors:  Esther Dirks; Phebe de Heus; Anja Joachim; Jessika-M V Cavalleri; Ilse Schwendenwein; Maria Melchert; Hans-Peter Fuehrer
Journal:  Pathogens       Date:  2021-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.